Han Zhu is a Cardiology physician affiliated with Palo Alto University. OpenAlex indexes 101 publications with 3,559 citations (h-index 26); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-723-4000Provider last certified this registry record 24 Aug 2020.
Clinical trials
- Multi-component HIV Intervention Packages for Chinese Men Who Have Sex With Men -Test, Link and Care (TLC)
Sponsor: Vanderbilt University Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
93.4%Beta blocker35%Metoprolol Succinate59%Carvedilol41%Part D≥29 patientsCalcium channel blocker16.9%Amlodipine Besylate100%Part D≥16 patients+ 6 more classes in this area
Blood & clotting
6.6%Factor Xa inhibitor6.6%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR Phenotyping
Stanford University
FY2026$722,135R01HL174432 - Identification of Causal T-Cell Mechanisms in Immune Checkpoint Inhibitor Induced Myocarditis
Stanford University
FY2026$166,320K08HL161405 - A Targeted Approach to Treat Immunotherapy-Induced Myocarditis with CXCR3 Blockade
Stanford University
FY2025$773,843R01HL177581
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology: A Scientific Statement From the American Heart Association
Circulation Genomic and Precision Medicine
2025 - Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis
Circulation Research
2025 - Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction
JACC CardioOncology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Tait Shanafelt, MD
Palo Alto University
Victor Froelicher, MD
Palo Alto University
Kimford Meador, MD
Palo Alto University
Michael Marmor, MD
Palo Alto University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”